ERO1L promotes IL6/sIL6R signaling and regulates MUC16 expression to promote CA125 secretion and the metastasis of lung cancer cells
2020 · Cell Death and Disease · 46 citations
https://doi.org/10.1038/s41419-020-03067-8
S
Sufei Zheng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
1.5K
Citations
19
h-index
25
i10-index
Sufei Zheng is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Lung Cancer Treatments and Mutations & Ferroptosis and cancer prognosis. The author has an h-index of 19, co-authored 45 publications.
Papers by this author
worksMolecular subtypes of neuroendocrine carcinomas: A cross-tissue classification framework based on five transcriptional regulators
2024 · Cancer Cell · 40 citations
https://doi.org/10.1016/j.ccell.2024.05.002
The membrane-bound and soluble form of melanotransferrin function independently in the diagnosis and targeted therapy of lung cancer
2020 · Cell Death and Disease · 16 citations
https://doi.org/10.1038/s41419-020-03124-2
Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity
2019 · Journal of Translational Medicine · 15 citations
https://doi.org/10.1186/s12967-019-2117-7
Spatially resolved atlas of breast cancer uncovers intercellular machinery of venular niche governing lymphocyte extravasation
2025 · Nature Communications · 8 citations
https://doi.org/10.1038/s41467-025-58511-0
KEAP1 mutations as key crucial prognostic biomarkers for resistance to KRAS-G12C inhibitors
2025 · Journal of Translational Medicine · 6 citations
https://doi.org/10.1186/s12967-025-06089-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat